These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 15496216

  • 1. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.
    Robinson M.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():30-7. PubMed ID: 15496216
    [Abstract] [Full Text] [Related]

  • 2. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P, Katz PO, Chen Y, Sostek M.
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [Abstract] [Full Text] [Related]

  • 3. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [Abstract] [Full Text] [Related]

  • 4. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 6. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ, Boer WA, Geldof H, Hazelhoff B, Bergmans P, Tytgat GN, Smout AJ.
    Aliment Pharmacol Ther; 2004 Aug 15; 20(4):451-8. PubMed ID: 15298640
    [Abstract] [Full Text] [Related]

  • 7. Optimizing acid-suppression therapy.
    Barnett JL, Robinson M.
    Manag Care; 2001 Oct 15; 10(10 Suppl):17-21. PubMed ID: 11729443
    [Abstract] [Full Text] [Related]

  • 8. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Oct 15; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases.
    Robinson M.
    Int J Clin Pract; 2005 Jun 15; 59(6):709-15. PubMed ID: 15924600
    [Abstract] [Full Text] [Related]

  • 10. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J.
    Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 6():11-9. PubMed ID: 15496214
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO, Koch FK, Ballard ED, Bagin RG, Gautille TC, Checani GC, Hogan DL, Pratha VS.
    Aliment Pharmacol Ther; 2007 Jan 15; 25(2):197-205. PubMed ID: 17229243
    [Abstract] [Full Text] [Related]

  • 12. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Jan 15; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 13. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI.
    Expert Rev Anti Infect Ther; 2005 Dec 15; 3(6):863-70. PubMed ID: 16307499
    [Abstract] [Full Text] [Related]

  • 14. The proton-pump inhibitors: similarities and differences.
    Horn J.
    Clin Ther; 2000 Mar 15; 22(3):266-80; discussion 265. PubMed ID: 10963283
    [Abstract] [Full Text] [Related]

  • 15. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M.
    Aliment Pharmacol Ther; 2004 Nov 15; 20 Suppl 6():1-10. PubMed ID: 15496213
    [Abstract] [Full Text] [Related]

  • 16. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Nov 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 17. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Nov 15; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 18. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss SF, Niv Y, Avni Y, Shirin H.
    Aliment Pharmacol Ther; 2004 Jul 01; 20(1):117-22. PubMed ID: 15225178
    [Abstract] [Full Text] [Related]

  • 19. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K, Lind T, Wilder-Smith C.
    Eur J Clin Pharmacol; 2004 Oct 01; 60(8):531-9. PubMed ID: 15349707
    [Abstract] [Full Text] [Related]

  • 20. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
    de Korwin JD, Ducrotté P, Vallot T.
    Presse Med; 2004 Jun 19; 33(11):746-54. PubMed ID: 15257232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.